Advertisement
Screener

MEDICINOVA, INC. (MNOV) Graph

MNOV Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $458.44K; Cost of revenue (m); Research and development $900.00K; Operating expenses $3.00M.
  • 2026-03-31: Revenue $186.98K; Cost of revenue (m); Research and development $1.20M; Operating expenses $3.02M.
  • 2025-12-31: Revenue $151.74K*; Cost of revenue (m); Research and development $1.40M*; Operating expenses $3.24M*.
  • 2025-09-30: Revenue $123.32K; Cost of revenue (m); Research and development $1.50M; Operating expenses $3.50M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MNOV revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$458.44KOperating expenses$3.00MOperating income-$2.54MOther income, net-$4.88KResearch & development$900.00KNet income-$2.31M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$458.44K(m)$900.00K$3.00M(m)-$2.31M
2026-03-31$186.98K(m)$1.20M$3.02M(m)-$2.59M
2025-12-31$151.74K*(m)$1.40M*$3.24M*(m)$21.19M*
2025-09-30$123.32K(m)$1.50M$3.50M(m)-$3.05M
2025-06-30$134.60K(m)$2.00M$3.74M(m)-$3.28M
2025-03-31(m)(m)$1.70M$3.20M(m)-$2.86M
2024-09-30(m)(m)$1.80M$3.31M(m)-$2.85M
2024-06-30(m)(m)$1.50M$3.05M(m)-$2.63M
2024-03-31(m)(m)$1.70M$3.14M(m)-$2.75M
2023-09-30$1.00M(m)$700.00K$2.15M(m)-$723.11K
2023-06-30(m)(m)$1.60M$3.30M(m)-$2.87M
2023-03-31(m)(m)$1.40M$2.96M(m)-$2.92M
2022-09-30(m)(m)$2.40M$3.90M(m)-$3.65M
2022-06-30(m)(m)$2.50M$4.09M(m)-$4.03M
2022-03-31(m)(m)$2.00M$3.41M(m)-$3.39M
2021-09-30$37.50K(m)$2.00M$3.64M(m)-$3.58M
2021-06-30(m)(m)$2.30M$4.31M(m)-$4.28M
2021-03-31$4.00M(m)$2.00M$4.20M(m)-$187.80K
2020-09-30(m)(m)$2.10M$3.73M(m)-$3.70M
2020-06-30(m)(m)$2.10M$4.51M(m)-$4.45M
2020-03-31(m)(m)$1.20M$2.92M(m)-$2.71M
2019-09-30(m)(m)$1.10M$2.65M(m)-$2.38M
2019-06-30(m)(m)$1.40M$4.18M(m)-$3.88M
2019-03-31(m)(m)$1.50M$4.98M(m)-$4.70M
2018-12-31(m)(m)(m)$492.00K(m)-$208.00K
2018-09-30(m)(m)$2.30M$7.03M$1.66K-$6.78M
2018-06-30(m)(m)$1.30M$3.40M$1.91K-$3.14M
2018-03-31(m)(m)$1.60M$4.67M(m)-$4.54M
2017-12-31(m)(m)(m)$3.41M(m)-$1.60M
2017-09-30(m)(m)$1.20M$3.79M$2.05K-$3.75M
2017-06-30(m)(m)$800.00K$2.81M$2.03K-$2.79M
2017-03-31(m)(m)$800.00K$3.02M$4.06K-$3.02M
2016-12-31(m)(m)(m)$1.44K(m)-$1.45K
2016-09-30(m)(m)$800.00K$2.85K$1.68K-$2.84K
2016-06-30(m)(m)$900.00K$3.21K$1.01K-$3.20K
2016-03-31(m)(m)$1.00M$3.39K$1.50K-$3.38K
2015-12-31(m)(m)(m)$2.74K(m)-$2.73K
2015-09-30(m)(m)$500.00K$1.59K$1.38K-$1.61K
2015-06-30(m)(m)$700.00K$2.28K$1.66K-$2.29K
2015-03-31$0.00(m)$600.00K$2.21K$2.95K-$2.21K
2014-12-31(m)(m)(m)$2.38K(m)-$2.38K
2014-09-30(m)(m)$800.00K$2.35K$1.47K-$2.34K
2014-06-30(m)(m)$700.00K$2.13K$1.55K-$2.12K
2014-03-31$0.00(m)$600.00K$2.36K$1.54K-$2.35K
2013-12-31$6.00M(m)(m)$2.57M(m)$3.41M
2013-09-30(m)(m)$600.00K$2.24M$1.81K-$2.24M
2013-06-30(m)(m)$800.00K$2.79M$1.79K-$2.79M
2013-03-31$3.00K(m)$500.00K$2.42M-$1.25K-$2.42M
2012-12-31$34.00K(m)(m)$2.46M(m)-$2.43M
2012-09-30$84.00K(m)$872.55K$2.45M$5.82K-$2.38M
2012-06-30$494.00K(m)$1.48M$2.78M(m)-$2.28M
2012-03-31$191.00K(m)$1.88M$4.06M(m)-$3.87M
2011-12-31(m)(m)(m)$3.50M(m)-$3.50M
2011-09-30$0.00$0.00$1.68M$3.91M$5.08K-$3.89M
2011-06-30$0.00$0.00$2.04M$3.72M$0.00-$4.68M
2011-03-31(m)(m)$2.62M$4.98M(m)-$5.66M
2010-09-30$0.00$0.00$2.18M$4.15M$6.58K-$5.70M
2010-06-30$0.00$0.00$2.30M$4.15M$0.00-$4.33M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$645.42K(m)$2.10M$6.02M(m)-$4.90M
2025-06-30$134.60K(m)$3.70M$6.94M(m)-$6.15M
2024-06-30(m)(m)$3.20M$6.18M(m)-$5.38M
2023-06-30(m)(m)$3.00M$6.26M(m)-$5.79M
2022-06-30(m)(m)$4.50M$7.50M(m)-$7.42M
2021-06-30$4.00M(m)$4.40M$8.51M(m)-$4.47M
2020-06-30(m)(m)$3.30M$7.43M(m)-$7.16M
2019-06-30(m)(m)$2.90M$9.16M(m)-$8.58M
2018-06-30(m)(m)$2.90M$8.07M$1.91K-$7.69M
2017-06-30(m)(m)$1.70M$5.83M$6.09K-$5.81M
2016-06-30(m)(m)$1.80M$6.60M$2.52K-$6.58M
2015-06-30(m)(m)$1.30M$4.49M$4.61K-$4.50M
2014-06-30(m)(m)$1.40M$4.49M$3.09K-$4.47M
2013-06-30$3.26K(m)$1.30M$5.21M$544.00-$5.21M
2012-06-30$684.80K(m)$3.36M$6.85M(m)-$6.15M
2011-06-30$0.00$0.00$4.66M$8.70M$0.00-$10.34M
2010-06-30$0.00$0.00$5.25M$9.39M-$751.00-$9.50M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$257.92K(m)$5.30M$10.45M(m)-$9.20M
2024-09-30(m)(m)$5.00M$9.49M(m)-$8.23M
2023-09-30$1.00M(m)$3.70M$8.41M(m)-$6.51M
2022-09-30(m)(m)$6.80M$11.40M(m)-$11.07M
2021-09-30$4.04M(m)$6.40M$12.15M(m)-$8.05M
2020-09-30(m)(m)$5.40M$11.16M(m)-$10.87M
2019-09-30(m)(m)$4.00M$11.81M(m)-$10.96M
2018-09-30(m)(m)$5.20M$15.09M$3.57K-$14.47M
2017-09-30(m)(m)$2.90M$9.62M$8.14K-$9.56M
2016-09-30(m)(m)$2.70M$9.44M$4.19K-$9.42M
2015-09-30(m)(m)$1.90M$6.09M$5.99K-$6.11M
2014-09-30(m)(m)$2.20M$6.84M$4.56K-$6.81M
2013-09-30$3.26K(m)$2.00M$7.45M$2.35K-$7.44M
2012-09-30$768.58K(m)$4.23M$9.29M$5.82K-$8.53M
2011-09-30$0.00$0.00$6.34M$12.61M$5.08K-$14.23M
2010-09-30$0.00$0.00$7.43M$13.54M$5.83K-$15.20M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$409.66K$6.70M$13.69M$5.99K$12.00M
2024-12-31(m)$6.80M$12.68M$5.54K$11.05M
2023-12-31$1.00M$5.30M$10.90M$3.05K$8.57M
2022-12-31(m)$8.70M$14.63M$2.82K-$14.07M
2021-12-31$4.04M$8.10M$14.25M$2.57K-$10.13M
2020-12-31(m)$7.10M$14.18M-$1.65K-$13.85M
2019-12-31(m)$5.70M$14.03M$12.66K-$12.94M
2018-12-31(m)$5.30M$15.59M$5.28K-$14.68M
2017-12-31(m)$3.90M$13.03M-$1.74M-$11.16M
2016-12-31(m)$3.10M$10.88M$3.75K-$10.87M
2015-12-31(m)$2.70M$8.82M$7.36K-$8.85M
2014-12-31(m)$2.90M$9.22M-$3.97K-$9.20M
2013-12-31(m)$2.70M$10.02M$4.04K-$4.03M
2012-12-31$802.58K$4.50M$11.75M$11.14K-$10.96M
2011-12-31(m)$7.78M$16.11M$11.57K-$17.73M
2010-12-31(m)$9.71M$17.88M$12.68K-$20.19M
2009-12-31(m)$10.87M$21.24M$7.01K-$20.37M
2008-12-31(m)(m)(m)(m)-$21.92M
2007-12-31(m)(m)(m)(m)-$48.90M
2006-12-31(m)(m)(m)(m)-$35.69M
2005-12-31(m)(m)(m)(m)-$25.69M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B